sorafenib has been researched along with akt-i-1,2 compound in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (akt-i-1,2 compound) | Trials (akt-i-1,2 compound) | Recent Studies (post-2010) (akt-i-1,2 compound) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 56 | 0 | 34 |
| Protein | Taxonomy | sorafenib (IC50) | akt-i-1,2 compound (IC50) |
|---|---|---|---|
| Low molecular weight phosphotyrosine protein phosphatase | Homo sapiens (human) | 7.43 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.2748 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5861 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 1.4843 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Morphy, R | 1 |
1 review(s) available for sorafenib and akt-i-1,2 compound
| Article | Year |
|---|---|
Selectively nonselective kinase inhibition: striking the right balance.
Topics: Animals; Antineoplastic Agents; Drug Design; Drug Discovery; Humans; Protein Binding; Protein Kinase Inhibitors; Structure-Activity Relationship | 2010 |
1 other study(ies) available for sorafenib and akt-i-1,2 compound
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |